Artificial Intelligence and Postoperative Acute Kidney Injury

NCT ID: NCT04705064

Last Updated: 2021-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to develop and validate an artificial intelligence model that predicts postoperative acute kidney injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative acute kidney injury is known to increase the length of hospital stay and healthcare cost. A lot of risk prediction models have been developed for identifying patients at increased risk of postoperative acute kidney injury. Recent advances in artificial intelligence make it possible to manage and analyze big data. Prediction model using an artificial intelligence and large-scale data can improve the accuracy of prediction performance. Furthermore, the use of an artificial intelligence may be a useful adjuvant tool in making clinical decisions or real-time prediction if it is integrated into the electrical medical record systems. However, before implementing an artificial intelligence model into the clinical setting, prospective evaluation of an artificial intelligence model's real performance is essential. However, to our knowledge, there was no artificial intelligence model for prediction of postoperative acute kidney injury, which was prospectively evaluated. Therefore, we aimed to develop an artificial intelligence model which predicts postoperative acute kidney injury and evaluate the model's performance prospectively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-cardiac Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AI_AKI

Adults patients undergoing non-cardiac surgery

Prediction of postoperative acute kidney injury using an artificial intelligence

Intervention Type DIAGNOSTIC_TEST

The performance of an artificial intelligence model to predict postoperative acute kidney injury will be tested prospectively.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prediction of postoperative acute kidney injury using an artificial intelligence

The performance of an artificial intelligence model to predict postoperative acute kidney injury will be tested prospectively.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults patients undergoing non-cardiac surgery

Exclusion Criteria

* Age under 18 years
* Surgery duration \< 1 hour
* Transplantation surgery
* Nephrectomy
* Cardiac surgery
* Patients who had severe kidney dysfunction preoperatively as follows:
* Serum creatinine ≄ 4 mg/dl
* Estimated glomerular filtration rate \<15 ml/min/1.73m2
* History of renal replacement therapy
* Patients who had no results of preoperative or postoperative serum creatinine
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hyung-Chul Lee

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hyung-Chul Lee

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hyung-Chul Lee, MD.PhD

Role: CONTACT

+821024566336

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hyung-Chul Lee, MD.PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-069-1180

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.